Overview

The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer

Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
To determine whether sorafenib is able to change pre-cancerous cells in a way that we believe is important in the progression of cancer.
Phase:
N/A
Details
Lead Sponsor:
University of Chicago
Collaborator:
Bayer
Treatments:
Niacinamide
Sorafenib